- Home
- ORIC vs CRTO Comparison
ORIC vs CRTO Comparison
Compare ORIC & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORIC | CRTO |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ORIC | CRTO |
|---|---|---|
| Price | $12.06 | $20.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | $19.73 | ★ $38.44 |
| AVG Volume (30 Days) | ★ 1.8M | 600.0K |
| Earning Date | 02-17-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.79 |
| EPS | N/A | ★ 3.00 |
| Revenue | N/A | ★ $1,956,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.51 |
| P/E Ratio | ★ N/A | $6.71 |
| Revenue Growth | N/A | ★ 0.53 |
| 52 Week Low | $3.90 | $19.00 |
| 52 Week High | $14.93 | $47.27 |
Technical Indicators
Market Signals| Indicator | ORIC | CRTO |
|---|---|---|
| Relative Strength Index (RSI) | 68.34 | 48.10 |
| Support Level | $11.52 | $19.02 |
| Resistance Level | $12.61 | $21.55 |
| Average True Range (ATR) | 0.83 | 0.89 |
| MACD | 0.33 | -0.01 |
| Stochastic Oscillator | 86.92 | 42.32 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.